4CPS-150 Use of adalimumab for hidradenitis suppurativa

BACKGROUND: Adalimumab is an antibody against tumour necrosis factor-α currently indicated for moderate to severe hidradenitis suppurative (HS). PURPOSE: To assess the effectiveness and safety of adalimumab in patients with HS. MATERIAL AND METHODS: A retrospective study of patients with HS and trea...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur J Hosp Pharm
Главные авторы: Gil-Sierra, MD, Garciadeparedes-Esteban, JC, Rios-Sanchez, E, Briceño-Casado, MDP, Palomo-Palomo, C, Diaz-Navarro, J, Rey, EJ Alegre-Del, Martinez-Diaz, C, Lopez-Vallejo, JF, Borrero-Rubio, JM
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2018
Предметы:
Section 4: Clinical pharmacy services
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535183/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.241
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы